Aceragen Inc Watch

from 8-K 3 pages Delaware the First State Page 1 2197526 8100 Authentication: 202505945 Sr# 20230152942 Date: 01-17-23 You May Verify This Certificate Online at CORP.DELAWARE.GOV/AUTHVER.SHTML I, Jeffrey W. Bullock, Secretary of State of the State of Delaware, Do Hereby Certify the Attached Is a True and Correct Copy of the Certificate of Amendment of “Idera Pharmaceuticals, Inc.”, Changing Its Name From "Idera Pharmaceuticals, Inc." to "Aceragen, Inc.", Filed in This Office on the Seventeenth Day of January, A.D. 2023, at 11:06 O`clock A.M. and I Do Hereby Further Certify That the Effective Date of the Aforesaid Certificate of Amendment Is the Seventeenth Day of January, A.D. 2023 at 4:59 O'CLOCK P.M. 23-3601-1 C2.5 P7 23-3601-1 C2.5 P8 23-3601-1 C2.5 P9

from 8-K 6 pages Terms of Preferred Stock

from 8-A12G 6 pages Terms of Preferred Stock

from 8-K 15 pages Second Amended and Restated By-Laws of Idera Pharmaceuticals, Inc. as Further Amended on November 17, 2022 Second Amended and Restated By-Laws

from 8-K 8 pages Idera Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series X Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware

from 8-K 16 pages Idera Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series Z Non-Voting Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware

from 8-K 1 page Certificate of Amendment to the Restated Certificate of Incorporation of Idera Pharmaceuticals, Inc

from 8-K 17 pages Certificate of Designations, Preferences and Rights of Series B1 Convertible Preferred Stock Series B2 Convertible Preferred Stock Series B3 Convertible Preferred Stock and Series B4 Convertible Preferred Stock of Idera Pharmaceuticals, Inc

from 10-Q 128 pages Restated Certificate of Incorporation of Hybridon, Inc

from 10-K 21 pages Amended and Restated By-Laws of Hybridon, Inc. as Further Amended on March 15, 1994 Amended and Restated By-Laws

from 425 2 pages First Amendment to the Amended and Restated By-Laws of Idera Pharmaceuticals, Inc. January 21, 2018

from 425 2 pages First Amendment to Amended and Restated By-Laws of Biocryst Pharmaceuticals, Inc

from 8-K 2 pages First Amendment to the Amended and Restated By-Laws of Idera Pharmaceuticals, Inc. January 21, 2018

from 10-Q 125 pages Restated Certificate of Incorporation of Hybridon, Inc

from 10-Q 1 page Idera Pharmaceuticals, Inc. Certificate of Elimination of Number of Shares of Preferred Stock Designated as Series E Convertible Preferred Stock

from 10-Q 1 page Idera Pharmaceuticals, Inc. Certificate of Elimination of Number of Shares of Preferred Stock Designated as Series D Convertible Preferred Stock

from 8-K 1 page Certificate of Amendment to the Restated Certificate of Incorporation of Idera Pharmaceuticals, Inc

from 8-K 4 pages Idera Pharmaceuticals, Inc. Certificate of Amendment of Certificate of Designations, Preferences and Rights of Series E Preferred Stock Pursuant to Section 242 of the General Corporation Law of the State of Delaware

from 8-K 7 pages Idera Pharmaceuticals, Inc. Certificate of Amendment of Certificate of Designations, Preferences and Rights of Series D Preferred Stock Pursuant to Section 242 of the General Corporation Law of the State of Delaware

from 8-K 15 pages Certificate of Designations, Preferences and Rights of Series E Preferred Stock of Idera Pharmaceuticals, Inc